Mast cell - tumor cell interaction related gene and microRNA expression profiles in oral squamous cell carcinoma

  • 0Department of Clinical Chemistry, University Medical Center Goettingen, Goettingen, Germany.

|

|

Summary

This summary is machine-generated.

Mast cells (MCs) and oral squamous cell carcinoma (OSCC) cells interact through specific signaling pathways and microRNAs (miRNAs). Targeting these interactions, like the CCL2/CCR2 axis, may offer new therapies for head and neck tumors.

Area Of Science

  • Oncology
  • Immunology
  • Molecular Biology

Background

  • Mast cells (MCs) are key players in the tumor microenvironment (TME) of oral squamous cell carcinoma (OSCC), influencing patient outcomes.
  • Understanding the molecular dialogue between MCs and OSCC cells is crucial for developing effective treatments.

Purpose Of The Study

  • To investigate gene and microRNA (miRNA) expression profiles of MCs and OSCC cells during co-culture.
  • To identify molecular mechanisms underlying MC-OSCC interactions in the TME.

Main Methods

  • Co-culture of human OSCC (PCI-13) and MC (LUVA) cell lines.
  • Transcriptome analysis for differentially expressed genes (DEGs) and miRNA sequencing.
  • Bioinformatic analysis and assessment of prognostic relevance in head and neck tumors.

Main Results

  • Identified differential gene expression in pathways like chemokine signaling (CCL2/CCR2 axis), TGF-β, TLR, PI3K/Akt, JAK/STAT, Ras/Raf/MAPK, and IP3.
  • Found significant differential expression of miRNAs including miR-142, miR-146a, miR-223 in tumor cells, and miR-381, miR-379 in MCs.
  • CCR2, miR-142, miR-146a, and miR-223 were identified as prognostically relevant in head and neck tumors.

Conclusions

  • The interplay between MCs and OSCC is complex, regulated by specific signaling pathways and miRNAs.
  • Findings provide a basis for future functional studies and targeted therapies to modulate MC-OSCC interactions in the TME.